Status:

COMPLETED

Chlorhexidine-Alcohol Versus Povidone Iodine-Alcohol, Combined or Not With Use of a Bundle of New Devices, for Prevention of Intravascular-catheter Colonization and Catheter Failure

Lead Sponsor:

Poitiers University Hospital

Conditions:

Intravascular-catheter Colonization

Catheter Failure

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

Short peripheral intravenous catheters (PVC) are the most frequently used invasive medical devices in hospitals. Unfortunately, PVCs often fail before the end of treatment due to the occurrence of com...

Eligibility Criteria

Inclusion

  • Adult (age ≥ 18 years) patients,
  • Having clinical indication for placement of a single PVC for at least 48 hours (no minimum port access during the study duration),
  • Willing and able to provide informed consent.

Exclusion

  • Known allergies to CHG, PVI, isopropanol or ethanol,
  • Participation to another clinical trial aimed at reducing PVC complications,
  • Suspicion of bloodstream infection at catheter insertion,
  • Skin injury a catheter insertion site increasing the risk of catheter infection,
  • PVC inserted extremely urgently, making it impossible to comply with the protocol,
  • Intravascular catheter in place within the last 2 days, or within the last 2 weeks and with local signs of catheter complication,
  • Difficult catheter insertion suspected (obesity, known IV drug users, non-visible venous network after placement of a tourniquet...),
  • Patients already enrolled in this study,
  • Terminal or moribund patient not expected to live more than one week,
  • Patients not benefiting from a Social Security scheme or not benefiting from it through a third party,
  • Persons benefiting from enhanced protection, namely minors, persons deprived of their liberty by a judicial or administrative decision, adults under legal protection.
  • Pregnant or breastfeeding women
  • Women at age to procreate and not using effective contraception

Key Trial Info

Start Date :

January 7 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 27 2019

Estimated Enrollment :

1000 Patients enrolled

Trial Details

Trial ID

NCT03757143

Start Date

January 7 2019

End Date

September 27 2019

Last Update

October 31 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital of Poitiers

Poitiers, France, 86021